AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Opelkonazole
Opelkonazole is being developed for aerosolized administration. Direct delivery into the lungs has been talked about a long time in the anti-fungal world. This company has taken it now into clinical trials. And so I believe they are either in phase two or phase three. It has pretty good activity against Canada species, including Candor Aris and Candid or Cruciia.